Hims & Hers Health, Inc.
NYSEHims & Hers Health closed Wednesday at $29.54, up fractionally on the day but essentially flat on the week, with the short position continuing its slow retreat from August highs even as the structural bear thesis remains firmly in place. Short covering has been steady, and the direction is unchanged from last week's note. Short interest now stands at 23.8% of the free float, down…
HIMS short interest utilization hits 92.06%, matching 52-week peak as earnings loom.
Hims & Hers Health closed Wednesday at $29.54, up fractionally on the day but essentially flat on the week, with the short position continuing its slow retreat from August highs even as the structural bear thesis…
Hims & Hers Health closed Tuesday at $28.70, down 5.7% on the week, and the story this week is one of gradual short covering running against a still-elevated bearish base ahead of a November earnings print. Short…
Snapshot as of 8 Oct 2026
Hims & Hers Health enters the week with the stock down another 4% — extending a bruising month that has now erased nearly 14% — while short interest edges quietly higher and the analyst community tries to find a…
Hims & Hers Health has handed back a chunk of the 16% rally flagged in the prior note, falling 10.4% on the week to close at $28.44 — a sharp reversal that reopens the question of whether that move was genuine demand…
Hims & Hers Health has staged a sharp reversal this week — up 16% to $31.75 — flipping the script on a note filed just days ago that described extreme hedging demand and relentless selling pressure. The positioning…
Hims & Hers Health is caught in a widening gap between a Street that nudged targets higher after earnings and a market that keeps selling the stock — down another 10% on the week to $27.39, extending a month-long…
Hims & Hers Health reported Q2 results on August 10 and the reaction was swift and negative — the stock fell 3.4% the next day and is now down 5.1% on the week to $30.51, extending a month-long slide of more than…
Hims & Hers Health heads into its August 3 earnings report with short interest re-entrenched, options positioning nudging more cautious, and a stock that just bounced 8% on Thursday after losing 17% over the prior…
Hims & Hers Health arrives at its August 3 earnings report with a week of contradictory signals: short interest nudged back up, the stock shed 10% in five sessions, yet the borrow market is quietly loosening and…
Hims & Hers Health enters its August 3 earnings report in a genuinely unusual place: short sellers have been cutting positions for weeks, yet options traders just turned more defensive than they've been in months. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HIMS — free to start on ORTEX.
Sign up for free →Open HIMS on ORTEX